PRESERVE与RESP评分预测生存的比较分析
该回顾性队列研究纳入2007至2015年99例接受VV-ECMO治疗的成人ARDS患者,外部验证并比较PRESERVE与RESP评分的预测准确性。院内及6个月生存率分别为23%和22%,两评分对院内生存的AUC为0.64和0.69(p=0.53),对6个月生存的AUC为0.66和0.69(p=0.68)。结论认为两评分在韩国ARDS队列中预测准确性相似。
要点
- PRESERVE与RESP评分在亚洲ARDS患者中均有预测价值。
- 两评分对院内及6个月生存的预测准确性相似。
- 该队列院内生存率23%,6个月生存率22%。
核心结论
- PRESERVE和RESP评分均可用于预测亚洲ARDS患者的生存,且在韩国ARDS队列中预测准确性相似。
研究设计与样本
- 回顾性队列研究,纳入2007至2015年连续99例接受VV-ECMO治疗的成人ARDS患者,计算PRESERVE和RESP评分并比较预测准确性。
主要发现
- 患者平均年龄54岁,男性占70%,院内生存率23%,6个月生存率22%。
- PRESERVE与RESP评分对院内生存的AUC分别为0.64和0.69(p=0.53)。
- PRESERVE与RESP评分对6个月生存的AUC分别为0.66和0.69(p=0.68)。
临床怎么用
- 在VV-ECMO启动时可用PRESERVE或RESP评分辅助预测ARDS患者生存,两者预测准确性相似。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Venovenous (VV) extracorporeal membrane oxygenation (ECMO) can be a life-saving therapy for patients with severe acute lung failure refractory to conventional therapy. The respiratory ECMO survival prediction (RESP) score and the predicting death for severe acute respiratory distress syndrome on VV-ECMO (PRESERVE) score were created to predict survival at the time of initiation of ECMO. This study aimed to validate both of these scores externally and to compare their predictive accuracies in patients with non-Western acute respiratory distress syndrome (ARDS). METHODS: In this retrospective cohort study, we reviewed and extracted data from electronic medical records of consecutive adult ARDS patients who were treated with VV-ECMO from 2007 to 2015. The PRESERVE and RESP scores were calculated for each patient. The outcomes of interest were inhospital and 6-month survival. RESULTS: In all, 99 patients were included. The mean age of the patients was 54 years, and male patients constituted 70% of the cohort. The inhospital and 6-month survival rates were 23% and 22%, respectively. Receiver-operating characteristics curve analysis of the PRESERVE and RESP scores showed area under the curve values of 0.64 and 0.69, respectively (p = 0.53), for inhospital survival. The receiver-operating characteristics areas under the curve for 6-month survival were 0.66 and 0.69, respectively (p = 0.68). The prognostic accuracies of the PRESERVE and RESP scores were thus similar. CONCLUSIONS: Both PRESERVE and RESP scores are useful for predicting survival in Asian ARDS patients, and both scores had similar prognostic accuracies in our Korean ARDS cohort.
引用
- Kang HR, Kim DJ, Lee J, et al. A Comparative Analysis of Survival Prediction Using PRESERVE and RESP Scores. Ann Thorac Surg. 2017. PMID: 28410641. doi:10.1016/j.athoracsur.2017.01.052
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。